A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
Karthik D NathTala ShekarkhandMeghan SalcedoAndriy DerkachSiobhan RuedaAisara ChansakulMalin HulcrantzNeha KordeUrvi A ShahCarlyn Rose TanDavid J ChungOscar B LahoudHani HassounAlexander M LesokhinHeather J LandauGunjan ShahMichael ScordoSergio A GiraltSaad Z UsmaniMikhail RoshalCarl Ola LandgrenSham MailankodyPublished in: Leukemia & lymphoma (2022)